Genmab
Tahamtan Ahmadi was promoted to Chief Medical Officer in February of 2021. Ahmadi joined back in 2017 and served as senior vice president and head of oncology. In this new role, Ahmadi leads research, discovery, regulatory and medical activities.
This person is not in any offices
Genmab
40 followers
Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.